InfraStrata CEO John Wood delivers robust operational update Watch Now

Pin to quick picksNuformix Share Price (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price: 8.85
Bid: 8.70
Ask: 9.00
Change: -0.15 (-1.67%)
Spread: 0.30 (3.45%)
Open: 8.85
High: 8.95
Low: 8.85
Yest. Close: 9.00
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Nuformix Plc Ord 0.1P

Nuformix is part of the Medicine and Biotech Research sector.

Nuformix Share Price
Price 8.85
Bid 8.70
Ask 9.00
Change -0.15 (-1.67%)
Volume 635,238
Open 8.85
High 8.95
Low 8.85
Close 9.00
Currency GBX
Currency GBX
Issue Country GB
Shares in Issue 461m
Market Capitalisation £41m
Market Size 50,000
52 Week High 14.75
52 Week High Date 24-Jun-2019
52 Week Low 1.90
52 Week Low Date 12-Feb-2019
# Trades 21
Vol. Sold 288,323
Sold Value £25.52k
Vol. Bought 306,915
Bought Value £27.16k
PE Ratio -18.061
Earnings -0.49
Dividend 0.00
Yield 0.00%

Recent Share Trades for Nuformix (NFX)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
17-Jul-1911:12:018.922,766Buy*8.709.00246.73O Ordinary
17-Jul-1911:11:258.9215,000Buy*8.709.001,338O Ordinary
17-Jul-1911:01:088.8225,000Sell*8.709.202,205O Ordinary
17-Jul-1910:59:048.87575,000Sell*8.709.206,656O Ordinary
17-Jul-1910:24:488.9133,810Sell*8.709.203,012O Ordinary
17-Jul-1910:02:079.06521,846Buy*8.709.201,980O Ordinary
17-Jul-1909:44:228.917,857Sell*8.709.20700.06O Ordinary
17-Jul-1909:36:369.1050,000Buy*8.709.204,550O Ordinary
17-Jul-1909:32:129.105,468Buy*8.709.20497.59O Ordinary
17-Jul-1909:20:129.107,241Buy*8.709.20658.93O Ordinary

Directors Deals for Nuformix (NFX)

Trade Date Action Notifier Price Currency Amount Holding
16-Aug-18Buy Kirk Siderman-Wolte held the position of Non-Executive Director at the time of this trade. Kirk Siderman-Wolte2.60GBX35,36435,364
31-Mar-18Notification of Holding Joanne Holland held the position of Chief Scientific Officer at the time of this trade. Joanne Holland0.00037,500,000
31-Mar-18Notification of Holding Daniel Gooding held the position of CEO at the time of this trade. Daniel Gooding0.00037,500,000
31-Mar-18Notification of Holding David Tapolczay held the position of Non-Executive Chairman at the time of this trade. David Tapolczay0.00045,000,000

Login to your account

Don't have an account? Click here to register.